Literature DB >> 26915488

PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.

Lizhi Tang1, Qingguo Lü1, Hongyi Cao2, Qiu Yang2, Nanwei Tong3.   

Abstract

AIMS: Polymorphism of rs2016520 in gene PPARD has been associated with lipid metabolism, obesity, metabolic syndrome and type 2 diabetes mellitus (T2DM). We aimed to study the association of rs2016520 with common metabolic traits in a large population of Han Chinese adults.
METHODS: The polymorphism was genotyped in 1409 subjects using Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS); all participants underwent standard clinical examination and a 75g oral glucose tolerance test (OGTT); associations between the polymorphism and metabolic traits and indices of insulin resistance and insulin sensitivity were analyzed.
RESULTS: There was no significant difference in genotypes between the normal glucose tolerance (NGT) and the prediabetes group (χ(2)=3.17, P=0.2), except a nominal difference of allele frequency (χ(2)=3.07, P=0.07). The G carrier presented lower fasting plasma glucose (FPG, P=0.03), lower 2h plasma glucose (Pdom=0.04) and lower fasting insulin (P=0.02), lower systolic blood pressure (SBP, P=0.03), lower HOMA-IR (P=0.02) and higher QUICKI (P=0.01). Moreover, rs2016520 polymorphism was associated with FPG (β=-0.09, P=0.05), it was also associated with indices of insulin resistance (HOMA-IR, β=-0.06, Pdom=0.02; fasting insulin, β=-0.04, P=0.02) and indices of insulin sensitivity (QUICKI, β=-0.01, P=0.004). In addition, we observed that the allele G was also associated with lower SBP (β=-1.29, P=0.04) and diastolic blood pressure (DBP, β=-0.09, P=0.01). However, the minor allele G was not associated with risk of metabolic disorders including prediabetes, overweight, hypertension and metabolic syndrome.
CONCLUSIONS: Polymorphism of rs2016520 in gene PPARD was associated with benign metabolic traits in a large cohort of Chinese adults. The G allele may confer protection from type 2 diabetes and hypertension in Han Chinese.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic; OGTT; PPARD; Prediabetes; rs2016520

Mesh:

Substances:

Year:  2016        PMID: 26915488     DOI: 10.1016/j.gene.2016.02.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Pro12Ala PPAR-γ2 and +294T/C PPAR-δ Polymorphisms and Association with Metabolic Traits in Teenagers from Northern Mexico.

Authors:  Martín A Carrillo-Venzor; Nancy R Erives-Anchondo; Janette G Moreno-González; Verónica Moreno-Brito; Angel Licón-Trillo; Everardo González-Rodríguez; Pilar Del Carmen Hernández-Rodríguez; Sandra A Reza-López; Verónica Loera-Castañeda; Irene Leal-Berumen
Journal:  Genes (Basel)       Date:  2020-07-10       Impact factor: 4.096

2.  PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.

Authors:  Tao Wang; Jin-Fang Song; Xue-Yan Zhou; Cheng-Lin Li; Xiao-Xing Yin; Qian Lu
Journal:  BMC Med Genomics       Date:  2021-11-12       Impact factor: 3.063

3.  Identification of potential miRNA-mRNA regulatory network and the key miRNAs in intramuscular and subcutaneous adipose.

Authors:  Hui Feng; Tianyi Liu; Salsabeel Yousuf; Xiuxiu Zhang; Wanlong Huang; Ai Li; Lingli Xie; Xiangyang Miao
Journal:  Front Vet Sci       Date:  2022-08-25

4.  Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.

Authors:  Jinfang Song; Na Li; Ruonan Hu; Yanan Yu; Ke Xu; Hongwei Ling; Qian Lu; Tingting Yang; Tao Wang; Xiaoxing Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-16       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.